The global intravascular imaging market size surpassed USD 390.22 million in 2023 and is estimated to increase from USD 411.37 million in 2024 to approximately USD 697.37 million by 2034. It is projected to grow at a CAGR of 5.42% from 2024 to 2034.
The global intravascular imaging market size is worth around USD 411.37 million in 2024 and is anticipated to reach around USD 697.37 million by 2034, growing at a CAGR of 5.42% over the forecast period 2024 to 2034. Increased usage of intravascular imaging modalities is expected to boost intravascular imaging market growth.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The intravascular imaging market includes cutting-edge medical imaging technologies designed for visualizing and assessing coronary arteries and blood vessels. Techniques such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are integral to diagnosing cardiovascular conditions and directing interventional treatments like angioplasty and stent placement. This innovative field of intravascular imaging transforms cardiovascular diagnostics and interventions by utilizing specialized methods to visualize the inner structures of arteries and veins directly within the blood vessels.
AI Impact on the Intravascular Image Market
Algorithms have the potential to significantly improve intravascular imaging by automating numerous tasks or calculations, uncovering new patterns or phenotypes in data, and offering alternative diagnostic insights. Moreover, In the realm of interventional cardiology, artificial intelligence (AI) can contribute to procedural guidance, enhance intravascular imaging, and provide supplementary information to operators. As AI progressively extends into interventional cardiology, it can fundamentally transform the intravascular imaging market.
Report Coverage | Details |
Market Size by 2034 | USD 697.37 Million |
Market Size in 2023 | USD 390.22 Million |
Market Size in 2024 | USD 411.37 Million |
Market Growth Rate from 2024 to 2034 | CAGR of 5.42% |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2034 |
Segments Covered | Product Type, Modality, End-user, and Regions |
Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Expanded applications in peripheral vascular and structural heart procedures
The intravascular imaging market is growing beyond its traditional focus on coronary interventions, now embracing a wider range of applications in peripheral vascular and structural heart procedures. This broadening scope creates new opportunities for growth and market penetration. The potential for expansion extends into peripheral vascular and structural heart procedures, moving beyond conventional coronary interventions.
Concerns regarding radiation exposure
Some intravascular imaging methods, like fluoroscopy, involve exposure to ionizing radiation, raising concerns about the potential health risks. These concerns might affect the adoption of these technologies and shape preferences among patients and healthcare providers. Additionally, the absence of standardization in both procedures and interpretations of intravascular imaging presents challenges that can hinder the intravascular imaging market growth.
Integration of ultrasound imaging
A notable trend in the intravascular imaging market is the integration of intravascular ultrasound with other imaging techniques, such as angiography and optical coherence tomography (OCT). This combination enhances diagnostic and imaging capabilities by providing a more comprehensive view. Healthcare providers aim to improve patient outcomes and reduce costs, which supports the continuation of this trend in the coming years. Furthermore, advancements are being made with more refined IVUS catheters, which feature smaller diameters and make the imaging of narrower blood vessels. Hence, IVUS technology is anticipated to become more prevalent across various healthcare settings due to the increasing demand for minimally invasive diagnostic and therapeutic solutions.
The instrument segment dominated the intravascular imaging market in 2023. In the Intravascular Imaging market, the instrument segment encompasses the medical devices and equipment utilized for imaging procedures within blood vessels. Additionally, these instruments are essential for diagnosing and managing cardiovascular diseases, as they offer high-resolution visuals of arteries and blood vessels. Detailed images assist cardiologists and healthcare professionals in evaluating vascular conditions, detecting blockages, and directing therapeutic interventions.
The software segment is expected to grow at the fastest rate in the intravascular imaging market over the forecast period. This is because Software is important in improving data analysis and interpretation and provides advanced processing and visualization features that complement imaging instruments. This aspect is expected to drive continued growth in the segment throughout the forecast period.
The trolley mounted segment led the intravascular imaging market in 2023. This segment provides versatility and facilitates convenient transportation and positioning during cardiovascular procedures. Trolley stands, and Cassette holders need to be tailored to suit individual patients. A variety of trolley stands and cassette holders are available to meet these needs. The transition from traditional analog X-ray technology to computer-aided radiography improves image communication and offers environmental benefits for you to take full advantage of the improved technology.
The handheld segment is anticipated to witness the fastest growth in the intravascular imaging market during the projected period. Handheld intravascular imaging devices address the need for point-of-care accessibility and greater procedural flexibility. They enable healthcare providers to perform imaging procedures at the bedside, in outpatient settings, or in scenarios where trolley-mounted systems might not be as suitable.
The hospital segment dominated the global intravascular imaging market in 2023. Medical imaging technology is typically found in mid-sized to large hospitals due to its potential to generate substantial outpatient revenue. This segment commands the largest market share, driven by its high utilization rates and extensive patient base.
The ambulatory surgical centers segment is projected to show the fastest growth in the intravascular imaging market over the forecast period. This trend highlights a move towards outpatient cardiovascular interventions. Ambulatory surgical centers (ASCs) provide a more accessible and cost-efficient option, especially for intravascular imaging procedures that involve minimally invasive techniques.
North America held a significant share of the global intravascular imaging market. This growth is supported by the region's strategic embrace of advanced medical technologies and a strong healthcare infrastructure. In the United States, the market for intravascular imaging technologies is expanding steadily, fueled by the rising prevalence of cardiovascular diseases and the demand for sophisticated diagnostic and interventional tools.
The U.S.’s dedication to healthcare research and development promotes innovation, facilitating the smooth integration of innovative intravascular imaging solutions. The advancements in image quality and device portability have significantly enhanced diagnostic precision and patient outcomes.
Asia Pacific is expected to grow at the fastest rate in the intravascular imaging market throughout the studied period. The upward trajectory of China’s intravascular imaging market is largely driven by a rise in cardiovascular diseases and enhanced healthcare investments. The growing incidence of conditions like coronary artery disease has spurred a demand for advanced diagnostic tools, including intravascular imaging. Additionally, the government’s emphasis on improving healthcare infrastructure and extending services to rural regions has further supported market expansion.
Segments Covered in the Report
By Product Type
By Modality
By End-user
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Intravascular Imaging Market
5.1. COVID-19 Landscape: Intravascular Imaging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Intravascular Imaging Market, By Product Type
8.1. Intravascular Imaging Market, by Product Type, 2024-2034
8.1.1 Instruments
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Software
8.1.2.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Intravascular Imaging Market, By Modality
9.1. Intravascular Imaging Market, by Modality, 2024-2034
9.1.1. Handheld
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Trolley Mounted
9.1.2.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Intravascular Imaging Market, By End-user
10.1. Intravascular Imaging Market, by End-user, 2024-2034
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Diagnostic Imaging Centers
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Ambulatory Surgical Centers
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Long-term Care Centers
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Intravascular Imaging Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.1.2. Market Revenue and Forecast, by Modality (2021-2034)
11.1.3. Market Revenue and Forecast, by End-user (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Modality (2021-2034)
11.1.4.3. Market Revenue and Forecast, by End-user (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Modality (2021-2034)
11.1.5.3. Market Revenue and Forecast, by End-user (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.2.2. Market Revenue and Forecast, by Modality (2021-2034)
11.2.3. Market Revenue and Forecast, by End-user (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Modality (2021-2034)
11.2.4.3. Market Revenue and Forecast, by End-user (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Modality (2021-2034)
11.2.5.3. Market Revenue and Forecast, by End-user (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Modality (2021-2034)
11.2.6.3. Market Revenue and Forecast, by End-user (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Modality (2021-2034)
11.2.7.3. Market Revenue and Forecast, by End-user (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.3.2. Market Revenue and Forecast, by Modality (2021-2034)
11.3.3. Market Revenue and Forecast, by End-user (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Modality (2021-2034)
11.3.4.3. Market Revenue and Forecast, by End-user (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Modality (2021-2034)
11.3.5.3. Market Revenue and Forecast, by End-user (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Modality (2021-2034)
11.3.6.3. Market Revenue and Forecast, by End-user (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Modality (2021-2034)
11.3.7.3. Market Revenue and Forecast, by End-user (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.4.2. Market Revenue and Forecast, by Modality (2021-2034)
11.4.3. Market Revenue and Forecast, by End-user (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Modality (2021-2034)
11.4.4.3. Market Revenue and Forecast, by End-user (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Modality (2021-2034)
11.4.5.3. Market Revenue and Forecast, by End-user (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Modality (2021-2034)
11.4.6.3. Market Revenue and Forecast, by End-user (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Modality (2021-2034)
11.4.7.3. Market Revenue and Forecast, by End-user (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.5.2. Market Revenue and Forecast, by Modality (2021-2034)
11.5.3. Market Revenue and Forecast, by End-user (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Modality (2021-2034)
11.5.4.3. Market Revenue and Forecast, by End-user (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Modality (2021-2034)
11.5.5.3. Market Revenue and Forecast, by End-user (2021-2034)
Chapter 12. Company Profiles
12.1. Acqiris
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. NIDEK CO. LTD.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. AGFA Healthcare
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Aculight Carl Zeiss AG
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Heidelberg Engineering Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Optopol
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Sonostar Technologies Co.Ltd.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. OPKO Health
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. AlazarTech
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client